CN1176687C - 一种增强智力延缓衰老的药物及其制备方法 - Google Patents
一种增强智力延缓衰老的药物及其制备方法 Download PDFInfo
- Publication number
- CN1176687C CN1176687C CNB021128340A CN02112834A CN1176687C CN 1176687 C CN1176687 C CN 1176687C CN B021128340 A CNB021128340 A CN B021128340A CN 02112834 A CN02112834 A CN 02112834A CN 1176687 C CN1176687 C CN 1176687C
- Authority
- CN
- China
- Prior art keywords
- medicine
- decoction
- water
- time
- nootropics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 229940079593 drug Drugs 0.000 title claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 239000004375 Dextrin Substances 0.000 claims abstract description 3
- 229920001353 Dextrin Polymers 0.000 claims abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 3
- 229930006000 Sucrose Natural products 0.000 claims abstract description 3
- 235000019425 dextrin Nutrition 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims abstract description 3
- 239000005720 sucrose Substances 0.000 claims abstract description 3
- 239000006228 supernatant Substances 0.000 claims abstract description 3
- 239000002664 nootropic agent Substances 0.000 claims description 15
- 230000001777 nootropic effect Effects 0.000 claims description 15
- 230000032683 aging Effects 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 32
- 210000004369 blood Anatomy 0.000 abstract description 32
- 208000024891 symptom Diseases 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 25
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 10
- 206010022437 insomnia Diseases 0.000 abstract description 10
- 206010008479 Chest Pain Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000009758 senescence Effects 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 9
- 210000000038 chest Anatomy 0.000 description 8
- 208000019914 Mental Fatigue Diseases 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 206010048623 Atrial hypertrophy Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004793 poor memory Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021128340A CN1176687C (zh) | 2002-03-28 | 2002-03-28 | 一种增强智力延缓衰老的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021128340A CN1176687C (zh) | 2002-03-28 | 2002-03-28 | 一种增强智力延缓衰老的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1383864A CN1383864A (zh) | 2002-12-11 |
CN1176687C true CN1176687C (zh) | 2004-11-24 |
Family
ID=4742286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021128340A Expired - Fee Related CN1176687C (zh) | 2002-03-28 | 2002-03-28 | 一种增强智力延缓衰老的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1176687C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101422517B (zh) * | 2007-10-30 | 2011-08-31 | 桂龙药业(安徽)有限公司 | 一种抗衰老、增强记忆的中药组合物及其制备方法 |
CN102631436B (zh) * | 2012-05-10 | 2013-08-21 | 梁乐亭 | 一种治疗脑萎缩的药剂 |
-
2002
- 2002-03-28 CN CNB021128340A patent/CN1176687C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1383864A (zh) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100337636C (zh) | 一种人参总次苷药物组合物及其制备方法和应用 | |
CN1915399A (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN1628786A (zh) | 一种治疗高脂血症的药物 | |
CN1726929A (zh) | 一种治疗糖尿病的药物组合物 | |
CN1698804A (zh) | 一种治疗胸痹、心悸的中药制剂及制备方法 | |
CN1176687C (zh) | 一种增强智力延缓衰老的药物及其制备方法 | |
CN1709404A (zh) | 一种防治中风疾病的中成药及其生产方法、用途 | |
CN1742968A (zh) | 治疗血管性痴呆的药物及其制备方法 | |
CN1686469A (zh) | 一种治疗冠心病的药物制剂及其制备方法 | |
CN1221280C (zh) | 一种治疗心脑血管疾病的中成药及其制备方法 | |
CN1785330A (zh) | 一种治疗高血压的药物及其制备方法 | |
CN1872273A (zh) | 一种治疗心脑血管疾病的药物组合物及其制备方法 | |
CN1973872A (zh) | 滋阴补肾强身健脑的药物及制备方法 | |
CN1233361C (zh) | 一种治疗心血管疾病的中药组合物 | |
CN1211111C (zh) | 一种降血脂中药 | |
CN1180832C (zh) | 一种降压通脉的中药制剂 | |
CN1593493A (zh) | 辅康艾制剂及其制备方法 | |
CN1582981A (zh) | 抗病毒的中药复方制剂 | |
CN1276764C (zh) | 一种中药组合物在制备治疗缺铁性贫血药物中的应用 | |
CN1085546C (zh) | 治疗冠心病、动脉硬化、高血压的药物 | |
CN1718191A (zh) | 人参总次苷口腔崩解片及其制备方法和应用 | |
CN1879836A (zh) | 一种用于治疗小儿目眨及多动抽动症的药物及制备方法 | |
CN1256978C (zh) | 一种补肾生精益元强壮的药物及其制备方法 | |
CN1257728C (zh) | 用于治疗糖尿病的中成药及其制备方法 | |
CN1537612A (zh) | 抗柯萨奇b病毒性心肌炎胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUILONG MEDICINE (ANHUI) CO., LTD. Free format text: FORMER OWNER: GUILONG MEDICINE CO., LTD., SHANXI Effective date: 20110425 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 034000 ECONOMIC DEVELOPMENT ZONE, XINZHOU CITY, SHANXI PROVINCE TO: 243100 DANGTU INDUSTRIAL PARK, MAANSHAN CITY, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110425 Address after: 243100 Anhui city of Ma'anshan province Dangtu Industrial Park Patentee after: Guilong Pharmacy (Anhui) Co., Ltd. Address before: 034000 Xinzhou Economic Development Zone, Shanxi Patentee before: Guilong Medicine Co., Ltd., Shanxi |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041124 Termination date: 20210328 |
|
CF01 | Termination of patent right due to non-payment of annual fee |